- 1 analyst, 1 voteThe latest Buy, Hold or Sell from every analyst covering a stock.
- Price targetsTheir average target, the range, and the upside against today's price.
- Radar picks →The stocks our model scores highest in each index.
Russell 2000 analyst ratings
1,952 stocks · 1,852 covered · 15,462 votes ·
Ranking as of analyst data of 7 Nov 2026
| #Stock | Price · day | Buy / Hold / Sell | Avg target · range (USD) | Upside | Latest target report | Next earnings | Data status | Analysts | Report dates |
|---|---|---|---|---|---|---|---|---|---|
| 28.49−0.21% | Buy 16 · Hold 1 · Sell 0 · 94% Buy | 36.7922.00–50.00 | +29.1%+8.30 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:53 ET | 1919 firms | avg 6 Aug13 May 2026 – 19 Oct 2026 | |
| 66.79+4.29% | Buy 16 · Hold 1 · Sell 1 · 89% Buy | 155.81130.00–178.00 | +133.3%+89.02 USD | 2 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:47 ET | 2019 firms | avg 17 Aug26 Mar 2026 – 2 Nov 2026 | |
| 6.16+8.45% | Buy 16 · Hold 0 · Sell 1 · 94% Buy | 21.8214.00–27.00 | +254.2%+15.66 USD | 30 OctPartial coverage · checked 6 Nov | 24 NovEstimated | Partial coverage6 Nov 04:46 ET | 1919 firms | avg 6 Jul24 Nov 2025 – 30 Oct 2026 | |
| 41.67+7.04% | Buy 16 · Hold 0 · Sell 1 · 94% Buy | 78.8665.00–93.00 | +89.2%+37.19 USD | 27 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 02:38 ET | 1919 firms | avg 10 Sep6 Apr 2026 – 27 Oct 2026 | |
| 11.22+0.72% | Buy 16 · Hold 3 · Sell 2 · 76% Buy | 16.609.00–20.00 | +48.0%+5.38 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:42 ET | 2222 firms | avg 5 Aug25 Jan 2026 – 21 Oct 2026 | |
| 8.72+15.96% | Buy 15 · Hold 1 · Sell 0 · 94% Buy | 23.1414.00–33.00 | +165.4%+14.42 USD | 14 OctPartial coverage · checked 6 Nov | 10 NovConfirmed | Partial coverage6 Nov 06:03 ET | 1817 firms | avg 21 Jun23 Dec 2025 – 14 Oct 2026 | |
| 26.41+2.09% | Buy 15 · Hold 3 · Sell 0 · 83% Buy | 47.6326.00–80.00 | +80.4%+21.22 USD | 4 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:50 ET | 1919 firms | avg 24 Jul25 Feb 2026 – 4 Nov 2026 | |
| 224.41+2.01% | Buy 15 · Hold 2 · Sell 0 · 88% Buy | 211.20145.00–255.00 | −5.9%−13.21 USD | 29 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:05 ET | 1917 firms | avg 8 Sep2 Jan 2026 – 29 Oct 2026 | |
| 31.24+1.93% | Buy 15 · Hold 4 · Sell 0 · 79% Buy | 48.6331.00–65.00 | +55.6%+17.39 USD | 29 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:44 ET | 2119 firms | avg 10 Aug14 Apr 2026 – 29 Oct 2026 | |
| 48.77−0.75% | Buy 15 · Hold 6 · Sell 0 · 71% Buy | 57.1952.00–67.00 | +17.3%+8.42 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:50 ET | 2222 firms | avg 4 Sep14 Jul 2026 – 21 Oct 2026 | |
| 14.75+0.14% | Buy 15 · Hold 2 · Sell 0 · 88% Buy | 19.7110.00–30.00 | +33.7%+4.96 USD | 6 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 08:13 ET | 1917 firms | avg 13 Jun28 Jan 2026 – 6 Oct 2026 | |
| 93.72+0.19% | Buy 15 · Hold 1 · Sell 0 · 94% Buy | 144.8087.00–200.00 | +54.5%+51.08 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:42 ET | 1918 firms | avg 18 Aug26 Feb 2026 – 21 Oct 2026 | |
| 2.85+10.47% | Buy 15 · Hold 1 · Sell 0 · 94% Buy | 5.672.40–9.00 | +99.0%+2.82 USD | 15 OctPartial coverage · checked 6 Nov | 11 NovEstimated | Partial coverage6 Nov 06:53 ET | 1717 firms | avg 8 Jul19 Mar 2026 – 15 Oct 2026 | |
| 1.13−2.59% | Buy 15 · Hold 1 · Sell 0 · 94% Buy | 10.085.00–25.00 | +792.3%+8.95 USD | 13 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 07:07 ET | 1716 firms | avg 6 Jun30 Dec 2025 – 13 Oct 2026 | |
| 17.43+0.52% | Buy 15 · Hold 6 · Sell 0 · 71% Buy | 23.3717.00–30.00 | +34.1%+5.94 USD | 20 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:56 ET | 2121 firms | avg 15 Aug3 Feb 2026 – 20 Oct 2026 | |
| 6.59+6.63% | Buy 15 · Hold 1 · Sell 0 · 94% Buy | 19.2012.00–26.00 | +191.4%+12.61 USD | 27 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:19 ET | 1818 firms | avg 6 Jul19 Mar 2026 – 27 Oct 2026 | |
| 81.77−0.54% | Buy 15 · Hold 5 · Sell 0 · 75% Buy | 96.3776.00–110.00 | +17.9%+14.60 USD | 7 OctPartial coverage · checked 6 Nov | 3 DecConfirmed | Partial coverage6 Nov 02:42 ET | 2322 firms | avg 30 Aug16 Mar 2026 – 7 Oct 2026 | |
| 21.15+1.24% | Buy 15 · Hold 2 · Sell 0 · 88% Buy | 48.9229.00–59.00 | +131.3%+27.77 USD | 6 OctPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 06:05 ET | 1817 firms | avg 29 Jul14 Apr 2026 – 6 Oct 2026 | |
| 21.23−0.05% | Buy 15 · Hold 6 · Sell 1 · 68% Buy | 30.4814.50–37.00 | +43.6%+9.25 USD | 22 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:49 ET | 2525 firms | avg 4 Aug16 Dec 2025 – 22 Oct 2026 | |
| 8.65+5.62% | Buy 15 · Hold 4 · Sell 1 · 75% Buy | 32.4520.00–42.00 | +275.2%+23.80 USD | 29 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 06:10 ET | 2121 firms | avg 13 Jul25 Mar 2026 – 29 Oct 2026 | |
| 18.07+4.09% | Buy 15 · Hold 3 · Sell 1 · 79% Buy | 34.0610.00–50.00 | +88.5%+15.99 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:51 ET | 2120 firms | avg 2 Aug10 Dec 2025 – 28 Oct 2026 | |
| 17.63+9.78% | Buy 15 · Hold 5 · Sell 1 · 71% Buy | 35.5912.00–100.00 | +101.9%+17.96 USD | 24 AugPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:09 ET | 2323 firms | avg 22 May2 Dec 2025 – 24 Aug 2026 | |
| 75.99+17.27% | Buy 14 · Hold 2 · Sell 0 · 88% Buy | 90.0779.00–108.00 | +18.5%+14.08 USD | 20 AugPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 02:38 ET | 1817 firms | avg 23 May9 Jan 2026 – 20 Aug 2026 | |
| 0.76+10.84% | Buy 14 · Hold 3 · Sell 0 · 82% Buy | 10.083.00–30.00 | +1,228.9%+9.32 USD | 23 SepPartial coverage · checked 6 Nov | 10 NovEstimated | Partial coverage6 Nov 08:13 ET | 2019 firms | avg 5 Aug27 Apr 2026 – 23 Sep 2026 | |
| 50.07+3.11% | Buy 14 · Hold 12 · Sell 0 · 54% Buy | 83.9544.00–291.00 | +67.7%+33.88 USD | 4 NovPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:39 ET | 2726 firms | avg 7 Jul22 Jan 2026 – 4 Nov 2026 | |
| 278.59+1.18% | Buy 14 · Hold 5 · Sell 0 · 74% Buy | 439.21310.00–500.00 | +57.7%+160.62 USD | 1 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:46 ET | 2020 firms | avg 7 Aug12 Jun 2026 – 1 Oct 2026 | |
| 27.16−5.10% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 38.3127.00–47.00 | +41.0%+11.15 USD | 12 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:04 ET | 1715 firms | avg 8 Aug5 May 2026 – 12 Oct 2026 | |
| 78.91+0.56% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 121.0092.00–170.00 | +53.3%+42.09 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:55 ET | 1616 firms | avg 7 Sep17 Feb 2026 – 21 Oct 2026 | |
| 15.00−2.09% | Buy 14 · Hold 3 · Sell 0 · 82% Buy | 19.2517.00–24.00 | +28.3%+4.25 USD | 19 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:44 ET | 1816 firms | avg 2 Jul4 Dec 2025 – 19 Oct 2026 | |
| 104.60+17.49% | Buy 14 · Hold 8 · Sell 0 · 64% Buy | 199.55115.00–340.00 | +90.8%+94.95 USD | 28 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:49 ET | 2524 firms | avg 15 Sep22 Dec 2025 – 28 Oct 2026 | |
| 18.13+5.71% | Buy 14 · Hold 6 · Sell 0 · 70% Buy | 28.7818.00–42.00 | +58.7%+10.65 USD | 27 OctPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 06:57 ET | 2222 firms | avg 30 Aug29 Jun 2026 – 27 Oct 2026 | |
| 2.39+3.02% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 13.505.00–26.00 | +464.9%+11.11 USD | 15 SepPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 06:57 ET | 1614 firms | avg 11 Jul19 Mar 2026 – 15 Sep 2026 | |
| 34.19+5.10% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 63.5046.00–110.00 | +85.7%+29.31 USD | 19 OctPartial coverage · checked 6 Nov | 9 NovEstimated | Partial coverage6 Nov 06:05 ET | 1616 firms | avg 20 Jul5 Mar 2026 – 19 Oct 2026 | |
| 27.39−0.47% | Buy 14 · Hold 2 · Sell 0 · 88% Buy | 28.2122.00–40.00 | +3.0%+0.82 USD | 2 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 04:45 ET | 1716 firms | avg 26 Jul23 Feb 2026 – 2 Oct 2026 | |
| 16.71−7.96% | Buy 14 · Hold 4 · Sell 0 · 78% Buy | 24.6916.00–30.00 | +47.7%+7.98 USD | 13 OctPartial coverage · checked 6 Nov | 24 NovConfirmed | Partial coverage6 Nov 03:18 ET | 1919 firms | avg 12 Aug31 Mar 2026 – 13 Oct 2026 | |
| 25.48+0.24% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 30.8326.00–38.00 | +21.0%+5.35 USD | 7 OctPartial coverage · checked 6 Nov | 14 DecEstimated | Partial coverage6 Nov 02:50 ET | 1515 firms | avg 13 Aug11 Jun 2026 – 7 Oct 2026 | |
| 102.86+7.12% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 138.8672.00–200.00 | +35.0%+36.00 USD | 27 OctPartial coverage · checked 6 Nov | 11 NovEstimated | Partial coverage6 Nov 02:41 ET | 1717 firms | avg 6 Aug13 Mar 2026 – 27 Oct 2026 | |
| 10.68+18.01% | Buy 14 · Hold 2 · Sell 0 · 88% Buy | 35.3822.00–43.00 | +231.2%+24.70 USD | 20 AugPartial coverage · checked 6 Nov | 10 NovConfirmed | Partial coverage6 Nov 04:08 ET | 1918 firms | avg 8 Jul12 May 2026 – 20 Aug 2026 | |
| 18.28+3.34% | Buy 14 · Hold 3 · Sell 0 · 82% Buy | 39.0823.00–50.00 | +113.8%+20.80 USD | 21 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:52 ET | 1919 firms | avg 10 Jul28 Nov 2025 – 21 Oct 2026 | |
| 7.62+3.25% | Buy 14 · Hold 4 · Sell 0 · 78% Buy | 25.3610.00–50.00 | +232.8%+17.74 USD | 28 SepPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:52 ET | 1916 firms | avg 23 Jun19 Dec 2025 – 28 Sep 2026 | |
| 12.28+3.19% | Buy 14 · Hold 3 · Sell 0 · 82% Buy | 25.3818.00–35.00 | +106.7%+13.10 USD | 30 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:53 ET | 1919 firms | avg 19 Oct23 Jul 2026 – 30 Oct 2026 | |
| 26.54+1.80% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 47.5035.00–60.00 | +79.0%+20.96 USD | 21 AugPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:00 ET | 1717 firms | avg 15 Jun15 Dec 2025 – 21 Aug 2026 | |
| 4.62+2.90% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 13.587.00–19.00 | +194.0%+8.96 USD | 11 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 06:18 ET | 1615 firms | avg 5 Aug6 Mar 2026 – 11 Oct 2026 | |
| 29.79−1.18% | Buy 14 · Hold 3 · Sell 0 · 82% Buy | 77.7134.00–125.00 | +160.9%+47.92 USD | 23 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 02:53 ET | 2020 firms | avg 9 Aug5 Dec 2025 – 23 Oct 2026 | |
| 31.03+5.29% | Buy 14 · Hold 4 · Sell 0 · 78% Buy | 37.1727.00–55.00 | +19.8%+6.14 USD | 16 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 02:36 ET | 2220 firms | avg 11 Aug25 Nov 2025 – 16 Oct 2026 | |
| 29.63+3.11% | Buy 14 · Hold 1 · Sell 0 · 93% Buy | 40.5032.00–60.00 | +36.7%+10.87 USD | 27 OctPartial coverage · checked 6 Nov | 9 NovConfirmed | Partial coverage6 Nov 03:03 ET | 1818 firms | avg 17 Aug9 Mar 2026 – 27 Oct 2026 | |
| 9.98+1.11% | Buy 14 · Hold 12 · Sell 1 · 52% Buy | 14.114.63–30.00 | +41.4%+4.13 USD | 20 OctPartial coverage · checked 6 Nov | — | Partial coverage6 Nov 05:55 ET | 2926 firms | avg 1 Sep8 May 2026 – 20 Oct 2026 | |
| 9.85+8.00% | Buy 14 · Hold 1 · Sell 1 · 88% Buy | 26.697.00–56.00 | +171.0%+16.84 USD | 5 OctPartial coverage · checked 6 Nov | 12 NovEstimated | Partial coverage6 Nov 06:13 ET | 1717 firms | avg 25 Jul24 Mar 2026 – 5 Oct 2026 | |
| 10.17+8.31% | Buy 13 · Hold 1 · Sell 0 · 93% Buy | 14.4510.00–20.00 | +42.1%+4.28 USD | 29 OctPartial coverage · checked 6 Nov | 12 NovConfirmed | Partial coverage6 Nov 05:59 ET | 1515 firms | avg 23 Aug13 May 2026 – 29 Oct 2026 | |
| 46.45+1.91% | Buy 13 · Hold 3 · Sell 0 · 81% Buy | 80.6450.00–140.00 | +73.6%+34.19 USD | 30 SepPartial coverage · checked 6 Nov | 11 NovEstimated | Partial coverage6 Nov 06:10 ET | 1717 firms | avg 3 Jul5 Mar 2026 – 30 Sep 2026 | |
- VRDN#51VIRIDIAN THERAPEUTICS ORS28.49−0.21%
Buy 16 · Hold 1 · Sell 0 · 94% Buy
Target 36.79 (22.00–50.00)+29.1%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 13 May 2026 – 19 Oct 2026 · avg 6 Aug 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CELC#52CELCUITY66.79+4.29%
Buy 16 · Hold 1 · Sell 1 · 89% Buy
Target 155.81 (130.00–178.00)+133.3%
Details
- Latest target report
- 2 Nov 2026
- Report dates
- 26 Mar 2026 – 2 Nov 2026 · avg 17 Aug 2026
- Analysts
- 20 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CLSK#53CLEANSPARK6.16+8.45%
Buy 16 · Hold 0 · Sell 1 · 94% Buy
Target 21.82 (14.00–27.00)+254.2%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 24 Nov 2025 – 30 Oct 2026 · avg 6 Jul 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- 24 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- KGS#54KODIAK GAS SERVICES INC41.67+7.04%
Buy 16 · Hold 0 · Sell 1 · 94% Buy
Target 78.86 (65.00–93.00)+89.2%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 6 Apr 2026 – 27 Oct 2026 · avg 10 Sep 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- CRGY#55CRESCENT ENERGY CLASS A11.22+0.72%
Buy 16 · Hold 3 · Sell 2 · 76% Buy
Target 16.60 (9.00–20.00)+48.0%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 25 Jan 2026 – 21 Oct 2026 · avg 5 Aug 2026
- Analysts
- 22 analysts · 22 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- AMPX#56AMPRIUS TECHNOLOGIES INC8.72+15.96%
Buy 15 · Hold 1 · Sell 0 · 94% Buy
Target 23.14 (14.00–33.00)+165.4%
Details
- Latest target report
- 14 Oct 2026
- Report dates
- 23 Dec 2025 – 14 Oct 2026 · avg 21 Jun 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- 10 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- BEAM#57BEAM THERAPEUTICS26.41+2.09%
Buy 15 · Hold 3 · Sell 0 · 83% Buy
Target 47.63 (26.00–80.00)+80.4%
Details
- Latest target report
- 4 Nov 2026
- Report dates
- 25 Feb 2026 – 4 Nov 2026 · avg 24 Jul 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- GKOS#58GLAUKOS224.41+2.01%
Buy 15 · Hold 2 · Sell 0 · 88% Buy
Target 211.20 (145.00–255.00)−5.9%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 2 Jan 2026 – 29 Oct 2026 · avg 8 Sep 2026
- Analysts
- 19 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- IDYA#59IDEAYA BIOSCIENCES31.24+1.93%
Buy 15 · Hold 4 · Sell 0 · 79% Buy
Target 48.63 (31.00–65.00)+55.6%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 14 Apr 2026 – 29 Oct 2026 · avg 10 Aug 2026
- Analysts
- 21 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- KNTK#60KINETIK HOLDINGS CLASS A48.77−0.75%
Buy 15 · Hold 6 · Sell 0 · 71% Buy
Target 57.19 (52.00–67.00)+17.3%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 14 Jul 2026 – 21 Oct 2026 · avg 4 Sep 2026
- Analysts
- 22 analysts · 22 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- KRRO#61KORRO BIO14.75+0.14%
Buy 15 · Hold 2 · Sell 0 · 88% Buy
Target 19.71 (10.00–30.00)+33.7%
Details
- Latest target report
- 6 Oct 2026
- Report dates
- 28 Jan 2026 – 6 Oct 2026 · avg 13 Jun 2026
- Analysts
- 19 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- MIRM#62MIRUM PHARMACEUTICALS93.72+0.19%
Buy 15 · Hold 1 · Sell 0 · 94% Buy
Target 144.80 (87.00–200.00)+54.5%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 26 Feb 2026 – 21 Oct 2026 · avg 18 Aug 2026
- Analysts
- 19 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- OVID#63OVID THERAPEUTICS2.85+10.47%
Buy 15 · Hold 1 · Sell 0 · 94% Buy
Target 5.67 (2.40–9.00)+99.0%
Details
- Latest target report
- 15 Oct 2026
- Report dates
- 19 Mar 2026 – 15 Oct 2026 · avg 8 Jul 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- 11 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- PALI#64PALISADE BIO INC1.13−2.59%
Buy 15 · Hold 1 · Sell 0 · 94% Buy
Target 10.08 (5.00–25.00)+792.3%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 30 Dec 2025 – 13 Oct 2026 · avg 6 Jun 2026
- Analysts
- 17 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- PENN#65PENN ENTERTAINMENT17.43+0.52%
Buy 15 · Hold 6 · Sell 0 · 71% Buy
Target 23.37 (17.00–30.00)+34.1%
Details
- Latest target report
- 20 Oct 2026
- Report dates
- 3 Feb 2026 – 20 Oct 2026 · avg 15 Aug 2026
- Analysts
- 21 analysts · 21 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SLDB#66SOLID BIOSCIENCES INC6.59+6.63%
Buy 15 · Hold 1 · Sell 0 · 94% Buy
Target 19.20 (12.00–26.00)+191.4%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 19 Mar 2026 – 27 Oct 2026 · avg 6 Jul 2026
- Analysts
- 18 analysts · 18 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- TTAN#67SERVICETITAN CLASS A81.77−0.54%
Buy 15 · Hold 5 · Sell 0 · 75% Buy
Target 96.37 (76.00–110.00)+17.9%
Details
- Latest target report
- 7 Oct 2026
- Report dates
- 16 Mar 2026 – 7 Oct 2026 · avg 30 Aug 2026
- Analysts
- 23 analysts · 22 firms
- Next earnings
- 3 Dec · Confirmed
- Research
- Partial coverage · checked 6 Nov
- TYRA#68TYRA BIOSCIENCES21.15+1.24%
Buy 15 · Hold 2 · Sell 0 · 88% Buy
Target 48.92 (29.00–59.00)+131.3%
Details
- Latest target report
- 6 Oct 2026
- Report dates
- 14 Apr 2026 – 6 Oct 2026 · avg 29 Jul 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- ACAD#69ACADIA PHARMACEUTICALS21.23−0.05%
Buy 15 · Hold 6 · Sell 1 · 68% Buy
Target 30.48 (14.50–37.00)+43.6%
Details
- Latest target report
- 22 Oct 2026
- Report dates
- 16 Dec 2025 – 22 Oct 2026 · avg 4 Aug 2026
- Analysts
- 25 analysts · 25 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- BCAX#70BICARA THERAPEUTICS INC8.65+5.62%
Buy 15 · Hold 4 · Sell 1 · 75% Buy
Target 32.45 (20.00–42.00)+275.2%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 25 Mar 2026 – 29 Oct 2026 · avg 13 Jul 2026
- Analysts
- 21 analysts · 21 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- DYN#71DYNE THERAPEUTICS18.07+4.09%
Buy 15 · Hold 3 · Sell 1 · 79% Buy
Target 34.06 (10.00–50.00)+88.5%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 10 Dec 2025 – 28 Oct 2026 · avg 2 Aug 2026
- Analysts
- 21 analysts · 20 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- JANX#72JANUX THERAPEUTICS17.63+9.78%
Buy 15 · Hold 5 · Sell 1 · 71% Buy
Target 35.59 (12.00–100.00)+101.9%
Details
- Latest target report
- 24 Aug 2026
- Report dates
- 2 Dec 2025 – 24 Aug 2026 · avg 22 May 2026
- Analysts
- 23 analysts · 23 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- CGON#73CG ONCOLOGY75.99+17.27%
Buy 14 · Hold 2 · Sell 0 · 88% Buy
Target 90.07 (79.00–108.00)+18.5%
Details
- Latest target report
- 20 Aug 2026
- Report dates
- 9 Jan 2026 – 20 Aug 2026 · avg 23 May 2026
- Analysts
- 18 analysts · 17 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- CMPX#74COMPASS THERAPEUTICS0.76+10.84%
Buy 14 · Hold 3 · Sell 0 · 82% Buy
Target 10.08 (3.00–30.00)+1,228.9%
Details
- Latest target report
- 23 Sep 2026
- Report dates
- 27 Apr 2026 – 23 Sep 2026 · avg 5 Aug 2026
- Analysts
- 20 analysts · 19 firms
- Next earnings
- 10 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- CRSP#75CRISPR THERAPEUTICS AG50.07+3.11%
Buy 14 · Hold 12 · Sell 0 · 54% Buy
Target 83.95 (44.00–291.00)+67.7%
Details
- Latest target report
- 4 Nov 2026
- Report dates
- 22 Jan 2026 – 4 Nov 2026 · avg 7 Jul 2026
- Analysts
- 27 analysts · 26 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- DAVE#76DAVE CLASS A278.59+1.18%
Buy 14 · Hold 5 · Sell 0 · 74% Buy
Target 439.21 (310.00–500.00)+57.7%
Details
- Latest target report
- 1 Oct 2026
- Report dates
- 12 Jun 2026 – 1 Oct 2026 · avg 7 Aug 2026
- Analysts
- 20 analysts · 20 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ENOV#77ENOVIS CORP27.16−5.10%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 38.31 (27.00–47.00)+41.0%
Details
- Latest target report
- 12 Oct 2026
- Report dates
- 5 May 2026 – 12 Oct 2026 · avg 8 Aug 2026
- Analysts
- 17 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- IRON#78DISC MEDICINE78.91+0.56%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 121.00 (92.00–170.00)+53.3%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 17 Feb 2026 – 21 Oct 2026 · avg 7 Sep 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- IRT#79INDEPENDENCE REALTY15.00−2.09%
Buy 14 · Hold 3 · Sell 0 · 82% Buy
Target 19.25 (17.00–24.00)+28.3%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 4 Dec 2025 – 19 Oct 2026 · avg 2 Jul 2026
- Analysts
- 18 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- LEU#80CENTRUS ENERGY CLASS A104.60+17.49%
Buy 14 · Hold 8 · Sell 0 · 64% Buy
Target 199.55 (115.00–340.00)+90.8%
Details
- Latest target report
- 28 Oct 2026
- Report dates
- 22 Dec 2025 – 28 Oct 2026 · avg 15 Sep 2026
- Analysts
- 25 analysts · 24 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- LFTO#81LIFTOFF MOBILE INC18.13+5.71%
Buy 14 · Hold 6 · Sell 0 · 70% Buy
Target 28.78 (18.00–42.00)+58.7%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 29 Jun 2026 – 27 Oct 2026 · avg 30 Aug 2026
- Analysts
- 22 analysts · 22 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- LRMR#82LARIMAR THERAPEUTICS2.39+3.02%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 13.50 (5.00–26.00)+464.9%
Details
- Latest target report
- 15 Sep 2026
- Report dates
- 19 Mar 2026 – 15 Sep 2026 · avg 11 Jul 2026
- Analysts
- 16 analysts · 14 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- MAZE#83MAZE THERAPEUTICS34.19+5.10%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 63.50 (46.00–110.00)+85.7%
Details
- Latest target report
- 19 Oct 2026
- Report dates
- 5 Mar 2026 – 19 Oct 2026 · avg 20 Jul 2026
- Analysts
- 16 analysts · 16 firms
- Next earnings
- 9 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- MGNI#84MAGNITE27.39−0.47%
Buy 14 · Hold 2 · Sell 0 · 88% Buy
Target 28.21 (22.00–40.00)+3.0%
Details
- Latest target report
- 2 Oct 2026
- Report dates
- 23 Feb 2026 – 2 Oct 2026 · avg 26 Jul 2026
- Analysts
- 17 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- MMED#85MINIMED INC16.71−7.96%
Buy 14 · Hold 4 · Sell 0 · 78% Buy
Target 24.69 (16.00–30.00)+47.7%
Details
- Latest target report
- 13 Oct 2026
- Report dates
- 31 Mar 2026 – 13 Oct 2026 · avg 12 Aug 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- 24 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- NAVN#86NAVAN CLASS A25.48+0.24%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 30.83 (26.00–38.00)+21.0%
Details
- Latest target report
- 7 Oct 2026
- Report dates
- 11 Jun 2026 – 7 Oct 2026 · avg 13 Aug 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 14 Dec · Estimated
- Research
- Partial coverage · checked 6 Nov
- ORKA#87ORUKA THERAPEUTICS INC102.86+7.12%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 138.86 (72.00–200.00)+35.0%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 13 Mar 2026 – 27 Oct 2026 · avg 6 Aug 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- 11 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- QBTS#88D WAVE QUANTUM10.68+18.01%
Buy 14 · Hold 2 · Sell 0 · 88% Buy
Target 35.38 (22.00–43.00)+231.2%
Details
- Latest target report
- 20 Aug 2026
- Report dates
- 12 May 2026 – 20 Aug 2026 · avg 8 Jul 2026
- Analysts
- 19 analysts · 18 firms
- Next earnings
- 10 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- RCUS#89ARCUS BIOSCIENCES18.28+3.34%
Buy 14 · Hold 3 · Sell 0 · 82% Buy
Target 39.08 (23.00–50.00)+113.8%
Details
- Latest target report
- 21 Oct 2026
- Report dates
- 28 Nov 2025 – 21 Oct 2026 · avg 10 Jul 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RGNX#90REGENXBIO7.62+3.25%
Buy 14 · Hold 4 · Sell 0 · 78% Buy
Target 25.36 (10.00–50.00)+232.8%
Details
- Latest target report
- 28 Sep 2026
- Report dates
- 19 Dec 2025 – 28 Sep 2026 · avg 23 Jun 2026
- Analysts
- 19 analysts · 16 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- RSI#91RUSH STREET INTERACTIVE CLASS A12.28+3.19%
Buy 14 · Hold 3 · Sell 0 · 82% Buy
Target 25.38 (18.00–35.00)+106.7%
Details
- Latest target report
- 30 Oct 2026
- Report dates
- 23 Jul 2026 – 30 Oct 2026 · avg 19 Oct 2026
- Analysts
- 19 analysts · 19 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- STOK#92STOKE THERAPEUTICS26.54+1.80%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 47.50 (35.00–60.00)+79.0%
Details
- Latest target report
- 21 Aug 2026
- Report dates
- 15 Dec 2025 – 21 Aug 2026 · avg 15 Jun 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- STTK#93SHATTUCK LABS INC4.62+2.90%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 13.58 (7.00–19.00)+194.0%
Details
- Latest target report
- 11 Oct 2026
- Report dates
- 6 Mar 2026 – 11 Oct 2026 · avg 5 Aug 2026
- Analysts
- 16 analysts · 15 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- VERA#94VERA THERAPEUTICS CLASS A29.79−1.18%
Buy 14 · Hold 3 · Sell 0 · 82% Buy
Target 77.71 (34.00–125.00)+160.9%
Details
- Latest target report
- 23 Oct 2026
- Report dates
- 5 Dec 2025 – 23 Oct 2026 · avg 9 Aug 2026
- Analysts
- 20 analysts · 20 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- ZETA#95ZETA GLOBAL HOLDINGS CLASS A31.03+5.29%
Buy 14 · Hold 4 · Sell 0 · 78% Buy
Target 37.17 (27.00–55.00)+19.8%
Details
- Latest target report
- 16 Oct 2026
- Report dates
- 25 Nov 2025 – 16 Oct 2026 · avg 11 Aug 2026
- Analysts
- 22 analysts · 20 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- ZYME#96ZYMEWORKS29.63+3.11%
Buy 14 · Hold 1 · Sell 0 · 93% Buy
Target 40.50 (32.00–60.00)+36.7%
Details
- Latest target report
- 27 Oct 2026
- Report dates
- 9 Mar 2026 – 27 Oct 2026 · avg 17 Aug 2026
- Analysts
- 18 analysts · 18 firms
- Next earnings
- 9 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- RUN#97SUNRUN INC9.98+1.11%
Buy 14 · Hold 12 · Sell 1 · 52% Buy
Target 14.11 (4.63–30.00)+41.4%
Details
- Latest target report
- 20 Oct 2026
- Report dates
- 8 May 2026 – 20 Oct 2026 · avg 1 Sep 2026
- Analysts
- 29 analysts · 26 firms
- Next earnings
- —
- Research
- Partial coverage · checked 6 Nov
- SGMT#98SAGIMET BIOSCIENCES SERIES A9.85+8.00%
Buy 14 · Hold 1 · Sell 1 · 88% Buy
Target 26.69 (7.00–56.00)+171.0%
Details
- Latest target report
- 5 Oct 2026
- Report dates
- 24 Mar 2026 – 5 Oct 2026 · avg 25 Jul 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- 12 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
- ABSI#99ABSCI CORP10.17+8.31%
Buy 13 · Hold 1 · Sell 0 · 93% Buy
Target 14.45 (10.00–20.00)+42.1%
Details
- Latest target report
- 29 Oct 2026
- Report dates
- 13 May 2026 – 29 Oct 2026 · avg 23 Aug 2026
- Analysts
- 15 analysts · 15 firms
- Next earnings
- 12 Nov · Confirmed
- Research
- Partial coverage · checked 6 Nov
- ANAB#100ANAPTYSBIO46.45+1.91%
Buy 13 · Hold 3 · Sell 0 · 81% Buy
Target 80.64 (50.00–140.00)+73.6%
Details
- Latest target report
- 30 Sep 2026
- Report dates
- 5 Mar 2026 – 30 Sep 2026 · avg 3 Jul 2026
- Analysts
- 17 analysts · 17 firms
- Next earnings
- 11 Nov · Estimated
- Research
- Partial coverage · checked 6 Nov
Showing 51–100 of 1,952Load more
About the Russell 2000 analyst ratings
US small-cap stocks in the Russell 2000. Smaller companies usually have fewer analysts.. For each stock Analyst Radar counts the latest Buy, Hold or Sell rating of every analyst who covers it within the chosen window (one vote per analyst) and averages their price targets in US dollars. Upside is the average target against the current price; the range is the lowest and highest target. The stocks our model scores highest are collected in Radar picks. Research is refreshed daily and prices stream live during the US session.
A summary of analyst opinion, not investment advice.